Class 5. Pulmonary Hypertension Associated with Hematological, Systemic, Metabolic, Nutritional and Other Disorders

Reversible pulmonary hypertension in a patient diagnosed with scurvy

Gregory Berra, Léon Genecand, Anais Juillet, Jean-François Deux, Paco Prada, Hajo Müller, Marco Roffi, Maurice BeghettiGeneva University Hospitals. Switzerland British Medical Journal Case ReportsBMJ Case Rep 2025; 18: DOI: 10.1136/bcr-2025-266143 AbstractThis case report describes a woman in her late 50s with reversible pulmonary hypertension (PH) due to scurvy, a rare vitamin C (ascorbic acid) deficiency in […]

Reversible pulmonary hypertension in a patient diagnosed with scurvy Read More »

Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival after Pediatric Hematopoietic Stem Cell Transplant

Michael A. Smith, Zachary Hutchinson, Elizabeth Colglazier, Claire Parker, Christine S. Higham, Jeffrey R. Fineman, Matt S. Zinter, Christopher C. Dvorak, Hythem M. NawaytouUniversity of California, San Francisco. Transplantation and Cellular TherapyTransplant Cell Ther 2025; DOI: 10.1016/j.jtct.2025.11.024 AbstractBackground: Many life-threatening complications of hematopoietic stem cell transplantation (HSCT) develop secondary to endothelial injury and dysfunction, including transplant-associated thrombotic

Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival after Pediatric Hematopoietic Stem Cell Transplant Read More »

Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study

Zahra Hudda, Aaron Webster, Eric Anderson, Priscila Badia, Rochelle Bagatell, Saleh Bhar, Alan Bidgoli, Karla Boyd, Sonali Chaudhury, Gabriel Salinas Cisneros, John Craddock, Stella M Davies, Ami V. Desai, Lianna Drobatz, Christopher C. Dvorak, Hannah Elkus, Vanessa A. Fabrizio, Jennifer H Foster, Ellen Fraint, Jason L. Freedman, Jorge Galvez, Mark Garcia, Ann Haight, Christine Higham,

Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study Read More »

Association Between Steady-State Lactate Dehydrogenase Levels and Sickle Cell Complications: A Systematic Review

Sagad O.O. Mohamed, Amged Mohammed, Fatima S.K. Salih, Hozifa A.M. Elgadal, Ayman A.A. Elsamany, Mohamed S.K. Salih, Huda M.A. Mustafa, Israa Elawad, Mona G.A. Ahmedkaroum, Safaa G.A. Saeed, Rowa E.A. Ibrahim, Esraa A. Mohamedien, Aya A.H. Babiker, Esraa T. Suliman, Eman O.E. MohamedUniversity of Khartoum. Médecins Sans Frontières. University of Bahri. Ibri Regional Hospital. Harlem

Association Between Steady-State Lactate Dehydrogenase Levels and Sickle Cell Complications: A Systematic Review Read More »

Scurvy, a not obsolete disorder: Clinical report in eight young children and literature review

Alessandra Di Nora, Maria Carla Finocchiaro, Francesco Pizzo, Trobia Gian Luca, Maria Elena Cucuzza, Antonella Di Stefano, Serena Spampinato, Silvia Marino, Martino Ruggieri, Piero PavoneUniversity of Catania. Cannizzaro Emergency Hospital. ARNAS Garibaldi Hospital.Italy Open MedicineOpen Med 2025; DOI: 10.1515/med-2024-1086 AbstractBackground: Vitamin C is a key to many important functions. It stimulates the immune system by protecting humans

Scurvy, a not obsolete disorder: Clinical report in eight young children and literature review Read More »

Combined haptoglobin and hemopexin therapy for the treatment of cardiopulmonary dysfunction in sickle cell disease

Melissa J. Lucero, Christina Lisk, Delaney Swindle, Francesca Cendali, Saini Setua, Kiruphagaran Thangaraju, Alamzeb Khan, David I. Pak, Quintin O’Boyle, Shuwei Lu, Robert Tolson, Seth Zaeske, Saqib Khan, Nishant Rana, Natalie Westover, Pavel Davizon-Castillio, Gemlyn George, Kathryn Hassell, Rachelle Nuss, Nathan Brinkman, Thomas Gentinetta, Christy Niemeyer, Pedro Cabrales, Andre Palmer, Angelo D’Alessandro, Paul W. Buehler,

Combined haptoglobin and hemopexin therapy for the treatment of cardiopulmonary dysfunction in sickle cell disease Read More »

Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors

Ayako Chida‐Nagai, Yukayo Terashita, Shinsuke Hirabayashi, Hirokuni Yamazawa, Yuko Cho, Atsushi ManabeHokkaido University.Japan Pulmonary CirculationPulm Circ 2025; 15: DOI: 10.1002/pul2.70165 AbstractPulmonary hypertension (PH) is a severe complication observed in pediatric patients after hematopoietic cell transplantation or chemotherapy. A review of records at Hokkaido University Hospital (2014-2024) identified four cases of PH, each with different etiologies, including

Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors Read More »

Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity

Varshini Babu, Jane A. Little, Claudia R. Morris, Roberto Machado, Simon Gibbs, Gregory A. Kato, Victor R. Gordeuk, MArk T. Gladwin, Yingze Zhang, Seyed Mehdi NouraieUniversity of Pittsburgh. University of North Carolina at Chapel Hill.  Emory University School of Medicine and Children’s Healthcare of Atlanta. Indiana University. Imperial College London. CSL Behring. University of Illinois

Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity Read More »

Cardiovascular disease in Sickle cell: mechanisms, diagnostics and therapeutic advances

Elio Haroun, Ankit Agrawal, Aro Daniela Arockiam, Joseph El Dahdah, Joseph Kassab, Michael Nakhla, Michel Chedid El Helou, Harsha Sanaka, Ziad Zalaquett, Simrat Kaur, Tiffany Dong, Rabi Hanna, Brian Griffin, Tom Kai Ming WangCleveland Clinic. United States HeartHeart 2025; DOI: 10.1136/heartjnl-2025-325837 AbstractCardiovascular complications are increasingly recognised as a major driver of morbidity and early mortality in patients

Cardiovascular disease in Sickle cell: mechanisms, diagnostics and therapeutic advances Read More »

Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension

Aurelia E. Reiser, Markus Thiersch, Max Gassmann, Martina U. Muckenthaler, Thomas Geiser, Mona Lichtblau, Silvia UlrichUniversity of Zürich. University of Heidelberg. University of Berne.Switzerland and Germany Pulmonary CirculationPulm Circ 2025; 15: DOI: 10.1002/pul2.70142 AbstractIron deficiency (ID) is prevalent in pulmonary hypertension(PH), but there is no consensus on ID definition and its possible correlation to prognostic markers.

Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension Read More »

Scroll to Top